Literature DB >> 26664412

Corrigendum to "Electroacupuncture Treatment Improves Neurological Function Associated with Regulation of Tight Junction Proteins in Rats with Cerebral Ischemia Reperfusion Injury".

Ya-Min Zhang1, Hong Xu1, Hua Sun1, Su-Hui Chen1, Fu-Ming Wang1.   

Abstract

[This corrects the article DOI: 10.1155/2014/989340.].

Entities:  

Year:  2015        PMID: 26664412      PMCID: PMC4668313          DOI: 10.1155/2015/898474

Source DB:  PubMed          Journal:  Evid Based Complement Alternat Med        ISSN: 1741-427X            Impact factor:   2.629


We have noticed an inadvertent error in our paper “Electroacupuncture Treatment Improves Neurological Function Associated with Regulation of Tight Junction Proteins in Rats with Cerebral Ischemia Reperfusion Injury” [1]. There is an error that occurred during uploading Figure 4(a). The published picture of claudin-5 M5 is incorrect. We have attached a corrected version of Figure 4. This error does not change the scientific conclusions of the paper in any way.
Figure 4

Effects of EA on the distribution and expression of ZO-1, claudin-5, and occludin on ischemic cerebral microvessels. (a) Representative immunohistochemistry stained tissue of the following groups: sham; M1–M7: MCAO groups after 1, 3, 5, and 7 d of reperfusion; and E1–E7: EA groups after 1, 3, 5, and 7 d of reperfusion. The integrated optical density of ZO-1 (b), claudin-5 (c), and occludin (d). Data (n = 6) are represented as mean ± SD. ΔP < 0.05 versus the sham group, ⋆P < 0.05 versus the MCAO group at the same time points, and P < 0.05 versus the EA groups at the same time points. Arrows show the immunoreactive positive area. Scale bar in A = 50 μm (×400).

  1 in total

1.  Electroacupuncture treatment improves neurological function associated with regulation of tight junction proteins in rats with cerebral ischemia reperfusion injury.

Authors:  Ya-Min Zhang; Hong Xu; Hua Sun; Su-Hui Chen; Fu-Ming Wang
Journal:  Evid Based Complement Alternat Med       Date:  2014-06-10       Impact factor: 2.629

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.